|
|||||
|
|

Alternative asset manager Ares Management (NYSE:ARES) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 22% year on year to $1.50 billion. Its non-GAAP profit of $1.45 per share was 14% below analysts’ consensus estimates.
Is now the time to buy ARES? Find out in our full research report (it’s free for active Edge members).
Ares Management closed the year with Q4 results that missed Wall Street’s expectations, prompting a significant negative market reaction. Management pointed to resilient credit quality and a rebound in transaction activity, as private equity firms accelerated deal-making late in the year. CEO Greg Mason highlighted that “the weighted average organic EBITDA growth rate of our borrowers was more than three times that of GDP” and emphasized the company’s ability to support its dividend through stable core earnings and a diversified portfolio. Nonetheless, the quarter’s underperformance was attributed to lower base rates and lingering caution in the M&A environment, with management openly acknowledging these headwinds.
Looking ahead, Ares Management’s outlook is shaped by a blend of optimism around continued origination momentum and caution regarding interest rate trends. Management anticipates that lower short-term rates will present an earnings headwind, but believes the company’s large and diversified lending platform, as well as its specialized industry verticals, can mitigate these pressures. CFO Scott indicated, "the decline in base rates during the fourth quarter will create about $0.1 per share of earnings headwind for us in 2026,” while CEO Mason expressed confidence that specialized lending and access to both institutional and retail capital will help weather market volatility and support dividend stability.
Management attributed the quarter’s results to increased transaction activity in the second half, strong portfolio diversification, and selective credit standards, while noting that interest rate declines dampened earnings relative to expectations.
Ares Management expects origination volumes, interest rate movements, and competitive dynamics to shape performance in the year ahead.
In the coming quarters, our analysts will monitor (1) the pace and quality of new originations, particularly in specialized sectors like software and healthcare; (2) the impact of interest rate movements and competitive shifts on lending margins and deal terms; and (3) credit performance and early warning signs within the core portfolio, especially as macro conditions evolve. The company’s ability to sustain disciplined underwriting and capitalize on market dislocations will also be a key signpost.
Ares currently trades at $124.16, down from $137.22 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| 13 hours | |
| Mar-12 | |
| Mar-12 | |
| Mar-12 | |
| Mar-11 | |
| Mar-11 | |
| Mar-11 | |
| Mar-07 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-06 | |
| Mar-04 | |
| Mar-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite